drugset / Trial / NCT01577407
Non Opioid Treatment for Experimental Dyspnea
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this protocol is to test the effects of the non opioid nefopam on experimental dyspnea and on the counterirritation (ie inhibition of one pain by another pain) induced by dyspnea in healthy subjects.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nefopam | Small molecule | 20 mg | Intravenous |
Indications
No indication recorded.